Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes.

Tofte N, Suvitaival T, Trost K, Mattila IM, Theilade S, Winther SA, Ahluwalia TS, Frimodt-Møller M, Legido-Quigley C, Rossing P.

Front Endocrinol (Lausanne). 2019 Nov 22;10:818. doi: 10.3389/fendo.2019.00818. eCollection 2019.

2.

Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes.

Tofte N, Suvitaival T, Ahonen L, Winther SA, Theilade S, Frimodt-Møller M, Ahluwalia TS, Rossing P.

Sci Rep. 2019 Nov 8;9(1):16398. doi: 10.1038/s41598-019-52916-w.

3.

Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study.

Jensen MT, Sogaard P, Gustafsson I, Bech J, Hansen TF, Almdal T, Theilade S, Biering-Sørensen T, Jørgensen PG, Galatius S, Andersen HU, Rossing P.

Diabetologia. 2019 Dec;62(12):2354-2364. doi: 10.1007/s00125-019-05009-2. Epub 2019 Oct 30.

PMID:
31664481
4.

Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients.

Ahonen L, Jäntti S, Suvitaival T, Theilade S, Risz C, Kostiainen R, Rossing P, Orešič M, Hyötyläinen T.

Metabolites. 2019 Sep 14;9(9). pii: E184. doi: 10.3390/metabo9090184.

5.

Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes.

Pilemann-Lyberg S, Rasmussen DGK, Hansen TW, Tofte N, Winther SA, Holm Nielsen S, Theilade S, Karsdal MA, Genovese F, Rossing P.

Diabetes Care. 2019 Sep;42(9):1760-1768. doi: 10.2337/dc18-2599. Epub 2019 Jul 1.

PMID:
31262950
6.

Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.

Winther SA, Øllgaard JC, Tofte N, Tarnow L, Wang Z, Ahluwalia TS, Jorsal A, Theilade S, Parving HH, Hansen TW, Hazen SL, Pedersen O, Rossing P.

Diabetes Care. 2019 Aug;42(8):1512-1520. doi: 10.2337/dc19-0048. Epub 2019 May 23.

PMID:
31123156
7.

Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.

Rotbain Curovic V, Theilade S, Winther SA, Tofte N, Eugen-Olsen J, Persson F, Hansen TW, Jeppesen J, Rossing P.

Diabetes Care. 2019 Jun;42(6):1112-1119. doi: 10.2337/dc18-1427. Epub 2019 Mar 18.

PMID:
30885954
8.

Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.

Pilemann-Lyberg S, Hansen TW, Tofte N, Winther SA, Theilade S, Ahluwalia TS, Rossing P.

Diabetes Care. 2019 Jun;42(6):1088-1094. doi: 10.2337/dc18-2173. Epub 2019 Mar 18.

PMID:
30885950
9.

A marker of type VI collagen formation (PRO-C6) is associated with higher arterial stiffness in type 1 diabetes.

Frimodt-Møller M, Hansen TW, Rasmussen DGK, Theilade S, Nielsen SH, Karsdal MA, Genovese F, Rossing P.

Acta Diabetol. 2019 Jun;56(6):711-712. doi: 10.1007/s00592-019-01306-9. Epub 2019 Mar 9. No abstract available.

PMID:
30852680
10.

Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes.

Hansen CS, Theilade S, Lajer M, Hansen TW, Rossing P.

Diabet Med. 2018 Nov;35(11):1596-1604. doi: 10.1111/dme.13777. Epub 2018 Aug 20.

PMID:
29999549
11.

Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes.

Pilemann-Lyberg S, Hansen TW, Persson F, Theilade S, Singh Ahluwalia T, Frystyk J, Rossing P.

Nephrol Dial Transplant. 2019 Apr 1;34(4):659-666. doi: 10.1093/ndt/gfy076.

PMID:
29660007
12.

Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetes.

Peeters SA, Engelen L, Buijs J, Theilade S, Rossing P, Schalkwijk CG, Stehouwer CDA.

J Diabetes Complications. 2018 Mar;32(3):325-329. doi: 10.1016/j.jdiacomp.2017.12.011. Epub 2018 Jan 3.

PMID:
29395841
13.

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.

Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Jorsal A, Parving HH, Tarnow L, Theilade S, Rossing P, Schalkwijk CG, Stehouwer CDA.

Cardiovasc Diabetol. 2017 Oct 25;16(1):139. doi: 10.1186/s12933-017-0620-9.

14.

Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients-the Thousand & 1 Study.

Theilade S, Rossing P, Jensen JS, Jensen MT.

Acta Diabetol. 2018 Jan;55(1):21-29. doi: 10.1007/s00592-017-1062-2. Epub 2017 Oct 16.

PMID:
29038853
15.

Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes.

Zobel EH, Theilade S, von Scholten BJ, Persson F, Tarnow L, Lajer M, Hansen TW, Rossing P.

Diabetes Care. 2017 Mar;40(3):e32-e33. doi: 10.2337/dc16-2428. Epub 2017 Jan 6. No abstract available.

PMID:
28062524
16.

Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping: a randomised, placebo-controlled, double-blind cross-over trial.

Hjortkjær HØ, Jensen T, Kofoed KF, Mogensen UM, Sigvardsen PE, Køber L, Hilsted KL, Corinth H, Theilade S, Hilsted J.

BMJ Open. 2016 Dec 5;6(12):e012307. doi: 10.1136/bmjopen-2016-012307.

17.

Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetes.

Persson F, Theilade S, Eugen-Olsen J, Rossing P, Parving HH.

J Diabetes Complications. 2016 Nov - Dec;30(8):1440-1442. doi: 10.1016/j.jdiacomp.2016.07.003. Epub 2016 Jul 16.

PMID:
27475262
18.

Early myocardial impairment in type 1 diabetes patients without known heart disease assessed with tissue Doppler echocardiography: The Thousand & 1 study.

Jensen MT, Sogaard P, Andersen HU, Gustafsson I, Bech J, Hansen TF, Theilade S, Almdal T, Rossing P, Jensen JS.

Diab Vasc Dis Res. 2016 Jul;13(4):260-7. doi: 10.1177/1479164116637310. Epub 2016 Apr 21.

PMID:
27190082
19.

suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal disease.

Theilade S, Rossing P, Eugen-Olsen J, Jensen JS, Jensen MT.

Eur J Endocrinol. 2016 Jun;174(6):745-53. doi: 10.1530/EJE-15-0986. Epub 2016 Mar 7.

PMID:
26951602
20.

Cuff inflations do not affect night-time blood pressure: comparison of 24 h ambulatory blood pressure measured by a cuff and a tonometric device in type 2 diabetes.

Petersen EH, Theilade S, Hansen TW, Lindhardt MK, Rossing P.

Blood Press Monit. 2015 Dec;20(6):369-72. doi: 10.1097/MBP.0000000000000140.

PMID:
26154852
21.

Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia--the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT).

Theilade S, Claggett B, Hansen TW, Skali H, Lewis EF, Solomon SD, Parving HH, Pfeffer M, McMurray JJ, Rossing P; TREAT investigators.

J Hum Hypertens. 2016 Jan;30(1):46-52. doi: 10.1038/jhh.2015.22. Epub 2015 Mar 26.

PMID:
25810068
22.

Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.

Theilade S, Hansen TW, Goetze JP, Rossing P.

Am J Hypertens. 2015 Jun;28(6):772-9. doi: 10.1093/ajh/hpu227. Epub 2014 Dec 1.

PMID:
25468806
23.

Urinary alpha- and pi-glutathione s-transferases in adult patients with type 1 diabetes.

von Scholten BJ, Theilade S, Lajer M, Rossing P.

Nephron Extra. 2014 Jul 31;4(2):127-33. doi: 10.1159/000365481. eCollection 2014 May.

24.

Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping of blood pressure during night time: protocol for a randomised, placebo-controlled, double-blind, two-way crossover study.

Hjortkær H, Jensen T, Kofoed K, Mogensen U, Køber L, Hilsted KL, Corinth H, Theilade S, Hilsted J.

BMJ Open. 2014 Oct 7;4(10):e006142. doi: 10.1136/bmjopen-2014-006142. Erratum in: BMJ Open. 2015;5(9):e006142corr1.

25.

Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetes.

Theilade S, Lajer M, Hansen TW, Rossing P.

Acta Diabetol. 2014 Dec;51(6):973-80. doi: 10.1007/s00592-014-0651-6. Epub 2014 Oct 2.

PMID:
25274394
26.

Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.

Rosenlund S, Theilade S, Hansen TW, Andersen S, Rossing P.

Acta Diabetol. 2014 Dec;51(6):955-62. doi: 10.1007/s00592-014-0619-6. Epub 2014 Oct 2.

PMID:
25274393
27.

Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.

Theilade S, Lyngbaek S, Hansen TW, Eugen-Olsen J, Fenger M, Rossing P, Jeppesen JL.

J Intern Med. 2015 Mar;277(3):362-371. doi: 10.1111/joim.12269. Epub 2014 Jun 23.

28.

Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.

Theilade S, Hansen TW, Rossing P.

Am J Hypertens. 2014 Sep;27(9):1152-9. doi: 10.1093/ajh/hpu030. Epub 2014 Mar 13.

PMID:
24627444
29.

24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes - a cross-sectional study.

Theilade S, Lajer M, Hansen TW, Joergensen C, Persson F, Andrésdottir G, Reinhard H, Nielsen SE, Lacy P, Williams B, Rossing P.

Cardiovasc Diabetol. 2013 Aug 27;12:122. doi: 10.1186/1475-2840-12-122.

30.

Tonometric devices for central aortic systolic pressure measurements in patients with type 1 diabetes: comparison of the BPro and SphygmoCor devices.

Theilade S, Hansen TW, Joergensen C, Lajer M, Rossing P.

Blood Press Monit. 2013 Jun;18(3):156-60. doi: 10.1097/MBP.0b013e328360fb19.

PMID:
23546451
31.

Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes.

Theilade S, Lajer M, Persson F, Joergensen C, Rossing P.

Diabetes Care. 2013 Mar;36(3):715-21. doi: 10.2337/dc12-0850. Epub 2012 Nov 27.

32.

Discrepancy between tonometric ambulatory and cuff-based office blood pressure measurements in patients with type 1 diabetes.

Theilade S, Lajer M, Joergensen C, Persson F, Rossing P.

J Clin Hypertens (Greenwich). 2012 Oct;14(10):686-93. doi: 10.1111/j.1751-7176.2012.00689.x. Epub 2012 Aug 3.

33.

Ambulatory tonometric blood pressure measurements in patients with diabetes.

Theilade S, Joergensen C, Persson F, Lajer M, Rossing P.

Diabetes Technol Ther. 2012 Jun;14(6):453-6. doi: 10.1089/dia.2012.0006. Epub 2012 Apr 23.

PMID:
22524631
34.

Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes.

Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P.

Diabet Med. 2012 Aug;29(8):990-4. doi: 10.1111/j.1464-5491.2012.03633.x.

PMID:
22414297
35.

Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.

Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P.

Diabet Med. 2012 Mar;29(3):337-44. doi: 10.1111/j.1464-5491.2011.03482.x.

PMID:
21988672
36.

The prevalence and relevance of the Brugada-type electrocardiogram in the Danish general population: data from the Copenhagen City Heart Study.

Pecini R, Cedergreen P, Theilade S, Haunsø S, Theilade J, Jensen GB.

Europace. 2010 Jul;12(7):982-6. doi: 10.1093/europace/euq077. Epub 2010 Mar 31.

PMID:
20356912

Supplemental Content

Loading ...
Support Center